BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 28415059)

  • 1. [A Case of Slowly Progressive Brain Metastasis with Minor Bleeding after Removal of and Chemotherapy for Non-Small Cell Lung Cancer].
    Matsufuji H; Shiozaki E; Nakatake Y; Yoshida K; Kamada K; Matsuo T
    No Shinkei Geka; 2017 Apr; 45(4):339-344. PubMed ID: 28415059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local treatment of oligometastatic recurrence in patients with resected non-small cell lung cancer.
    Yano T; Okamoto T; Haro A; Fukuyama S; Yoshida T; Kohno M; Maehara Y
    Lung Cancer; 2013 Dec; 82(3):431-5. PubMed ID: 24113550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma knife surgery in the management of brain metastases from lung carcinoma: a retrospective analysis of survival, local tumor control, and freedom from new brain metastasis.
    Jawahar A; Matthew RE; Minagar A; Shukla D; Zhang JH; Willis BK; Ampil F; Nanda A
    J Neurosurg; 2004 May; 100(5):842-7. PubMed ID: 15137603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine preoperative brain CT in resectable non-small cell lung cancer - Ten years experience from a tertiary UK thoracic center.
    Matys T; Drury R; David S; Rassl DM; Qian W; Rintoul RC; Screaton NJ
    Lung Cancer; 2018 Aug; 122():195-199. PubMed ID: 30032831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography-computed tomography for postoperative surveillance in non-small cell lung cancer.
    Choi SH; Kim YT; Kim SK; Kang KW; Goo JM; Kang CH; Kim JH
    Ann Thorac Surg; 2011 Nov; 92(5):1826-32; discussion 1832. PubMed ID: 22051278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of preoperative 18F-FDG PET/CT on survival of resected mono-metastatic non-small cell lung cancer.
    Tönnies S; Tönnies M; Kollmeier J; Bauer TT; Förster GJ; Kaiser D; Wernecke KD; Pfannschmidt J
    Lung Cancer; 2016 Mar; 93():28-34. PubMed ID: 26898611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of dual time point F-18 FDG-PET/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy.
    Satoh Y; Nambu A; Onishi H; Sawada E; Tominaga L; Kuriyama K; Komiyama T; Marino K; Aoki S; Araya M; Saito R; Maehata Y; Oguri M; Araki T
    Eur J Radiol; 2012 Nov; 81(11):3530-4. PubMed ID: 22178287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical treatment of primary lung cancer with synchronous brain metastases.
    Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for cases with no extracranial metastasis in whom brain metastasis is detected after resection of non-small cell lung cancer.
    Bae MK; Yu WS; Byun GE; Lee CY; Lee JG; Kim DJ; Chung KY
    Lung Cancer; 2015 May; 88(2):195-200. PubMed ID: 25770646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of total lesion glycolysis by 18F-FDG PET/CT in surgically resected stage IA non-small cell lung cancer.
    Park SY; Cho A; Yu WS; Lee CY; Lee JG; Kim DJ; Chung KY
    J Nucl Med; 2015 Jan; 56(1):45-9. PubMed ID: 25525185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of non-small cell lung cancer with synchronous brain metastases treated with gamma knife radiosurgery.
    Kong DS; Lee JI; Nam DH; Park K; Kim JH; Kim JG; Park JO; Park K
    J Korean Med Sci; 2006 Jun; 21(3):527-32. PubMed ID: 16778400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for post-recurrence survival in patients with completely resected Stage I non-small-cell lung cancer.
    Song IH; Yeom SW; Heo S; Choi WS; Yang HC; Jheon S; Kim K; Cho S
    Eur J Cardiothorac Surg; 2014 Feb; 45(2):262-7. PubMed ID: 23811122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain Imaging for Staging of Patients With Clinical Stage IA Non-small Cell Lung Cancer in the National Lung Screening Trial: Adherence With Recommendations From the Choosing Wisely Campaign.
    Balekian AA; Fisher JM; Gould MK
    Chest; 2016 Apr; 149(4):943-50. PubMed ID: 26356134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of recurrence of non-small cell lung cancer after therapy using CT and Integrated PET/CT.
    Opoka L; Szołkowska M; Podgajny Z; Kunikowska J; Barańska I; Błasińska-Przerwa K; Jakubowska L; Rudziński P; Bestry I; Roszkowski-Śliż K
    Pneumonol Alergol Pol; 2013; 81(3):214-20. PubMed ID: 23609428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of FDG-PET findings of brain metastasis from non-small-cell lung cancer and small-cell lung cancer.
    Lee HY; Chung JK; Jeong JM; Lee DS; Kim DG; Jung HW; Lee MC
    Ann Nucl Med; 2008 May; 22(4):281-6. PubMed ID: 18535878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardized Uptake Values in the Primary Lesions of Non-Small-Cell Lung Cancer in FDG-PET/CT Can Predict Regional Lymph Node Metastases.
    Nakamura H; Saji H; Marushima H; Kimura H; Tagaya R; Kurimoto N; Hoshikawa M; Takagi M
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1388-93. PubMed ID: 25900205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery of primary lung cancer with oligometastatic m1b synchronous single brain metastasis: analysis of 37 cases.
    Cheufou DH; Welter S; Chalvatzoulis E; Christof D; Theegarten D; Stamatis G
    Thorac Cardiovasc Surg; 2014 Oct; 62(7):612-5. PubMed ID: 25136943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does initial staging or tumor histology better identify asymptomatic brain metastases in patients with non-small cell lung cancer?
    Shi AA; Digumarthy SR; Temel JS; Halpern EF; Kuester LB; Aquino SL
    J Thorac Oncol; 2006 Mar; 1(3):205-10. PubMed ID: 17409858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors and long-term survival in surgically treated brain metastases from non-small cell lung cancer.
    Enders F; Geisenberger C; Jungk C; Bermejo JL; Warta R; von Deimling A; Herold-Mende C; Unterberg A
    Clin Neurol Neurosurg; 2016 Mar; 142():72-80. PubMed ID: 26816105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.